They can also influence the tumor immune microenvironment, secreting factors such as CXCL12, which can limit the penetration of cytotoxic T cells into the tumor, thereby reducing the effectiveness of immunotherapies [252]. This evidence concerns the gene CXCL12 and neoplasm.